clobazam

Generic: clobazam

Labeler: camber pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name clobazam
Generic Name clobazam
Labeler camber pharmaceuticals, inc.
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

clobazam 2.5 mg/mL

Manufacturer
Camber Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 31722-641
Product ID 31722-641_f4e0965c-10a9-5b3c-e053-2995a90a4a5f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209796
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2020-02-24

Pharmacologic Class

Established (EPC)
benzodiazepine [epc]
Mechanism of Action
cytochrome p450 2d6 inhibitors [moa] cytochrome p450 3a4 inducers [moa]
Chemical Structure
benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 31722641
Hyphenated Format 31722-641

Supplemental Identifiers

RxCUI
1366192
UPC
0331722641128
UNII
2MRO291B4U
NUI
N0000175694 M0002356 N0000182137 N0000185506

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clobazam (source: ndc)
Generic Name clobazam (source: ndc)
Application Number ANDA209796 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 1 BOTTLE, GLASS in 1 CARTON (31722-641-12) / 120 mL in 1 BOTTLE, GLASS
source: ndc

Packages (1)

Ingredients (1)

clobazam (2.5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f4e0965c-10a9-5b3c-e053-2995a90a4a5f", "openfda": {"nui": ["N0000175694", "M0002356", "N0000182137", "N0000185506"], "upc": ["0331722641128"], "unii": ["2MRO291B4U"], "rxcui": ["1366192"], "spl_set_id": ["c9b51794-3cfa-4a34-b5bb-d523b5798c17"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_moa": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, GLASS in 1 CARTON (31722-641-12)  / 120 mL in 1 BOTTLE, GLASS", "package_ndc": "31722-641-12", "marketing_start_date": "20200224"}], "brand_name": "Clobazam", "product_id": "31722-641_f4e0965c-10a9-5b3c-e053-2995a90a4a5f", "dosage_form": "SUSPENSION", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]"], "product_ndc": "31722-641", "dea_schedule": "CIV", "generic_name": "Clobazam", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Clobazam", "active_ingredients": [{"name": "CLOBAZAM", "strength": "2.5 mg/mL"}], "application_number": "ANDA209796", "marketing_category": "ANDA", "marketing_start_date": "20200224", "listing_expiration_date": "20261231"}